The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic technologies.

--Zimmer Biomet Holdings, Inc., a global medical technology leader, and Monogram Technologies Inc., an orthopedic robotics company, today announced they have entered into a definitive agreement ...

Upon closing of the proposed transaction, Zimmer Biomet expects to have a clear pathway to become the first and only company in orthopedics to offer a fully autonomous surgical robot.

Zimmer Biomet and Monogram undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this ...

Zimmer Biomet , a medical technology company, and Monogram Technologies , an orthopedic robotics company, has entered into a definitive agreement for Zimmer Biomet to acquire all outstanding ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported net sales of $1.909 million in Q1, reflecting a 1.1% increase on a reported basis and a 2.3% rise when excluding the effects of foreign currency. While ...

Investing.com - Citi has reiterated its Neutral rating and $104.00 price target on Zimmer Biomet (NYSE:ZBH), currently trading near its 52-week low at $93.99, following the company’s ...

Zimmer Biomet Holdings, Inc., a global medical technology leader, and Monogram Technologies Inc., an orthopaedic robotics company, announced they have entered into a definitive agreement for Zimmer ...

Ratings for Zimmer Biomet Holdings (NYSE:ZBH) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary ...